RxDoctor Payments Data

Victor Hsu, MD

Orthopaedic Surgery · Chalfont, PANPI 1942210018

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $153,678 of the $212,176 with a category attached, or 72.4%. 24 manufacturers reported payments, led by The Institute Of Musculoskeletal Science And Education at 52.7% of the total. Reporting peaked in 2021 at $55,852 and has fallen 98.8% since, to $690 in 2025. Among orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$212,176in general payments, 2019–2025

Across 160 payments — averaging $1326.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • The Institute Of Musculoskeletal Science And Education$112K
  • Altus Partners. LLC$56K
  • Medtronic$15K
  • Medical Device Business Services, Inc.$8K
  • Depuy Synthes Products, Inc.$6K
  • Medicrea USA, Corp.$5K
  • plus $10K from 18 others
$49,998in ownership & investment interests, 2019–2025

Across 3 payments — averaging $16,666 each. An ownership or investment interest held by the physician or an immediate family member.

  • Happe Spine$50K

What the payments were for

  • Royalty or licence$153,67872%
  • Consulting fees$44,85121%
  • Speaking & faculty fees$3,6002%
  • Travel & lodging$5,7063%
  • Food & beverage$3,7982%
  • Education$130%
  • Gifts$5300%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$212,176 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$413,222
Medicare patients
522
Services billed
1,226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin49$603
Methylprednisolone18$85
Tizanidine Hcl20$79
Prednisone13$45

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Chalfont

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →